https://biotechmorning.com/news/ebola-pill-obeldesivir-trial-congo-outbreak Biotech Morning en 2026-07-15T14:27:16.832Z An Ebola Pill Gets Its First Real Test in the Middle of an Outbreak https://biotechmorning.com/news/insilico-bora-ai-drug-manufacturing-partnership Biotech Morning en 2026-07-15T14:26:21.188Z The $2.5 Billion Handshake That Could Rewrite How Drugs Get Made https://biotechmorning.com/news/biogen-diranersen-alzheimers-phase-2-tau-phase-3 Biotech Morning en 2026-07-15T14:25:27.744Z Biogen's Alzheimer's Drug Failed Its Test. They're Betting Billions Anyway. https://biotechmorning.com/news/celcuity-gedatolisib-fda-approval-breast-cancer Biotech Morning en 2026-07-15T14:24:37.795Z The $10 Million Drug That Just Turned Celcuity Into a $5 Billion Company https://biotechmorning.com/news/attovia-ipo-dupixent-challenger Biotech Morning en 2026-07-15T14:23:39.977Z The Bet to Dethrone Immunology's Biggest Cash Cow https://biotechmorning.com/news/fda-distributed-manufacturing-biologics-framework Biotech Morning en 2026-07-15T14:22:47.006Z The FDA Wants to Build Drug Factories Inside Hospitals https://biotechmorning.com/news/fda-final-guidance-psychedelic-clinical-trials Biotech Morning en 2026-07-15T14:21:53.735Z The FDA Just Wrote a Rulebook for Tripping https://biotechmorning.com/news/q32-bio-alopecia-stock-surge Biotech Morning en 2026-07-14T14:29:05.540Z The Hair-Loss Drug That Just Made Investors 60% Richer Overnight https://biotechmorning.com/news/fda-silent-three-months-14-rejection-letters Biotech Morning en 2026-07-14T14:28:17.284Z The FDA Went Silent for Three Months. Then 14 Rejection Letters Dropped at Once. https://biotechmorning.com/news/dostarlimab-rectal-cancer-tumors-vanish Biotech Morning en 2026-07-14T14:27:27.028Z The Cancer Drug That Made Tumors Vanish in Every Single Patient https://biotechmorning.com/news/roche-divarasib-beats-sotorasib-adagrasib-kras-nsclc Biotech Morning en 2026-07-14T14:26:33.769Z Roche Just Beat Both Rivals in the Biggest KRAS Showdown Yet https://biotechmorning.com/news/oxford-bundibugyo-ebola-vaccine-trial Biotech Morning en 2026-07-14T14:25:39.431Z Ebola Has No Vaccine. Oxford Just Changed That. https://biotechmorning.com/news/big-pharma-china-drug-licensing-110-billion-record Biotech Morning en 2026-07-14T14:24:39.331Z Big Pharma Can't Stop Shopping in China https://biotechmorning.com/news/leqembi-at-home-alzheimers-drug-fda-approval Biotech Morning en 2026-07-14T14:23:46.648Z The Alzheimer's Drug That Just Escaped the Waiting Room